The LOCATE trial was a prospective, U.S., multicenter, open-label study investigating the impact of 18 F-fluciclovine PET/CT imaging on patient management of biochemically recurrent prostate cancer ...
DURHAM, N.C. -- A new multi-institutional study led by investigators at Duke University Medical Center indicates that a diagnostic scan may help localize recurrent prostate disease in men who have had ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results